Buscar
Mostrando ítems 1-10 de 8934
Study of Schistosoma mansoni Isolates from Patients with Failure of Treatment with Oxamniquine
(Fundação Oswaldo Cruz. Instituto Oswaldo Cruz., 2020)
Prediction score for antimony treatment failure in patients with ulcerative leishmaniasis lesions
(Public Library of Science, 2012)
Background: Increased rates for failure in leishmaniasis antimony treatment have been recently recognized worldwide. Although several risk factors have been identified there is no clinical score to predict antimony therapy ...
Association of the Endobiont Double-Stranded RNA Virus LRV1 With Treatment Failure for Human Leishmaniasis Caused by Leishmania braziliensis in Peru and Bolivia
(Oxford University Press, 2015)
Cutaneous and mucosal leishmaniasis, caused in South America by Leishmania braziliensis, is difficult to cure by chemotherapy (primarily pentavalent antimonials [Sb(V)]). Treatment failure does not correlate well with ...
Treatment failure in community-adquired pneumonia: coccidioidomycosis in a traveler patient
(SOC CHILENA INFECTOLOGIA, 2013)
Treatment failure in community-acquired pneumonia is defined as a clinical condition with inadequate response to antimicrobial therapy. Resistant and unusual microorganisms and noninfectious causes are responsible for ...
Treatment failure in leishmaniasis: Drug-resistance or another (epi-) phenotype?
(Taylor and Francis, 2014)
Two major leishmaniasis treatments have shown a significant decrease in effectiveness in the last few decades, mostly in the Indian subcontinent but also in other endemic areas. Drug resistance of Leishmania correlated ...
Triclabendazole for the treatment of human fascioliasis and the threat of treatment failures
(Taylor and Francis, 2021)
Introduction: The only drug effective against the infection caused by Fasciola hepatica or F. gigantica is triclabendazole (TCBZ), recommended by the WHO and recently approved by the FDA. Here, we describe the evolution ...
Treatment failure in intestinal strongyloidiasis: An indicator of HTLV-I infection
(Elsevier, 2002)
Background: The association of severe strongyloides with HTLV-I is well known; however, the seroprevalence of HTLV-I in other groups with strongyloidiasis is still unknown. We conducted a prospective study in patients with ...
Predictors of Hepatitis C Treatment Failure After Using Direct-Acting Antivirals in People Living With Human Immunodeficiency Virus
Background. Little is known about the influence of ongoing barriers to care in the persistence of hepatitis C virus (HCV) viremia after treatment with direct-acting antivirals (DAAs) among people living with human ...
A Case-Control Study on the Association Between Intestinal Helminth Infections and Treatment Failure in Patients With Cutaneous Leishmaniasis
(Oxford University Press, 2020)
BACKGROUND: Endemic regions of cutaneous leishmaniasis (CL) and intestinal helminthiasis overlap. CL treatment with systemic pentavalent antimonial drugs (Sb(5+)) fails in 10%-30% of patients. The study objective was to ...